Publication | Closed Access
CNS tumours The first study of dabrafenib in pediatric patients with BRAF V600–mutant relapsed or refractory low-grade gliomas
19
Citations
0
References
2016
Year
Neuro-oncologyRefractory Low-grade GliomasTumoral PathologyPediatric Brain TumorsGliomaMalignant DiseaseBraf V600–mutantMedicinePediatric PatientsPathologyBrain Tumor BiologyHigh-grade GliomasNeuropathologyOncologyRadiation Oncology
No additional data available for this publication yet. Check back later!